tiprankstipranks
Trending News
More News >
Aequus Pharmaceuticals Inc (TSE:AQS)
:AQS
Canadian Market

Aequus Pharmaceuticals (AQS) Income Statement

Compare
14 Followers

Aequus Pharmaceuticals Income Statement

Last quarter (Q2 2025), Aequus Pharmaceuticals's total revenue was C$218.22K, an increase of 35.19% from the same quarter last year. In Q2, Aequus Pharmaceuticals's net income was C$-163.91K. See Aequus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 584.24KC$ 254.90KC$ 1.38MC$ 2.71MC$ 2.59M
Gross Profit
C$ 199.97KC$ 143.66KC$ 1.15MC$ 2.69MC$ 2.59M
Operating Expenses
C$ 2.46MC$ 2.96MC$ 3.64MC$ 4.06MC$ 3.12M
Depreciation and Amortization
C$ 132.33KC$ 138.16KC$ 129.83KC$ 128.11KC$ 210.97K
EBITDA
C$ -1.79MC$ -2.68MC$ -2.87MC$ -1.23MC$ -314.80K
Operating Income
C$ -2.13MC$ -2.82MC$ -2.50MC$ -1.35MC$ -521.57K
Other Income/Expenses
C$ -50.46KC$ -144.44KC$ -712.01KC$ -442.14KC$ -519.26K
Pretax Income
C$ -2.18MC$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05M
Net Income
C$ -2.18MC$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.01
Diluted EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.01
Weighted Average Shares Outstanding
132.63M 132.63M 132.63M 128.85M 93.18M
Weighted Average Shares Outstanding (Diluted)
132.63M 132.63M 132.63M 128.85M 93.18M
Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History